Remission and cognitive ability in a cohort of patients with schizophrenia

被引:74
作者
Helldin, Lars [1 ]
Kane, John M.
Karilampi, Ua
Norlander, Torsten
Archer, Trevor
机构
[1] NU Hlth Care, Dept Psychiat, SE-46185 Trollhattan, Sweden
[2] Zucker Hillside Hosp, Glen Oaks, NY 11004 USA
[3] Albert Einstein Coll Med, Glen Oaks, NY 11004 USA
[4] Univ Gothenburg, Dept Psychol, SE-40530 Gothenburg, Sweden
[5] Karlstad Univ, Dept Psychol, SE-65188 Karlstad, Sweden
[6] Kalmar Univ, Dept Hlth & Behav Sci, SE-39182 Kalmar, Sweden
关键词
schizophrenia; remission; cognition;
D O I
10.1016/j.jpsychires.2006.07.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Patients with schizophrenia were studied regarding their ability of achieving symptomatic remission. It was found that only approximately one-third of the patients fulfilled the criteria for remission. The importance of cognitive performance was studied to decide whether cognitive ability is a contributing factor for achieving remission. Materials and methods: A homogeneous cohort of 211 patients, of whom 76 patients attained remission (36%), and. 135 patients (64%) failed to, was studied. Remission was decided by the use of eight items from the PANSS in which none of these items should have a score above three points. The patients were also tested on a comprehensive battery of cognitive tests including vigilance, working memory, longterm memory, executive functioning, learning performance, visuomotor speed/efficacy, cognitive flexibility and pre-morbid functioning. Results: Marked differences were exhibited in the cognitive abilities in all domains of patients who had attained remission in comparison with those who had not. Discussion: This study highlights the importance of cognitive performance as one possible predictor of remission. Patients without remission had lower cognitive ability and may have more difficulty in benefiting from, or complying with their treatment. As a consequence, various forms of supportive treatment might increase the likelihood of remission. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:738 / 745
页数:8
相关论文
共 53 条
[1]   Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study [J].
Addington, J ;
Addington, D .
SCHIZOPHRENIA RESEARCH, 2000, 44 (01) :47-56
[2]   Patterns of premorbid functioning in first-episode psychosis: initial presentation [J].
Addington, J ;
van Mastrigt, S ;
Addington, D .
SCHIZOPHRENIA RESEARCH, 2003, 62 (1-2) :23-30
[3]   Remission in schizophrenia: Proposed criteria and rationale for consensus [J].
Andreasen, NC ;
Carpenter, WT ;
Kane, JM ;
Lasser, RA ;
Marder, SR ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (03) :441-449
[4]  
[Anonymous], 2002, UNDERSTANDING TREATI
[5]  
[Anonymous], 2004, Neuropsychological Assessment
[6]   LONG-TERM DEPOT ANTIPSYCHOTICS - A RISK-BENEFIT ASSESSMENT [J].
BARNES, TRE ;
CURSON, DA .
DRUG SAFETY, 1994, 10 (06) :464-479
[7]   Neurocognitive enhancement therapy with work therapy -: Effects on neuropsychological test performance [J].
Bell, M ;
Bryson, G ;
Greig, T ;
Corcoran, C ;
Wexler, BE .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) :763-768
[8]   Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode [J].
Caspi, A ;
Reichenberg, A ;
Weiser, M ;
Rabinowitzc, J ;
Kaplan, Z ;
Knobler, H ;
Davidson-Sagi, N ;
Davidson, M .
SCHIZOPHRENIA RESEARCH, 2003, 65 (2-3) :87-94
[9]   THE CONTINUOUS PERFORMANCE-TEST, IDENTICAL PAIRS VERSION (CPT-IP) .1. NEW FINDINGS ABOUT SUSTAINED ATTENTION IN NORMAL-FAMILIES [J].
CORNBLATT, BA ;
RISCH, NJ ;
FARIS, G ;
FRIEDMAN, D ;
ERLENMEYERKIMLING, L .
PSYCHIATRY RESEARCH, 1988, 26 (02) :223-238
[10]   Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis [J].
Donohoe, G ;
Owens, N ;
O'Donnell, C ;
Burke, T ;
Moore, L ;
Tobin, A ;
O'Callaghan, E .
EUROPEAN PSYCHIATRY, 2001, 16 (05) :293-298